Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Tumor Necrosis Factor Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Tumor Necrosis Factor Inhibitorsmarket, defines the market attractiveness level of Tumor Necrosis Factor Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Tumor Necrosis Factor Inhibitors industry, describes the types of Tumor Necrosis Factor Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global Tumor Necrosis Factor Inhibitors market and the development prospects and opportunities of Tumor Necrosis Factor Inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Tumor Necrosis Factor Inhibitors market in Chapter 13.
By Player:
Intas Pharmaceuticals
Dexa Medica
GlaxoSmithKline
LEO Pharma
LG Life Sciences
MedImmune
Momenta Pharmaceuticals
Janssen Biotech
HanAll Biopharma
Bionovis
EPIRUS Biopharmaceuticals
CASI Pharmaceuticals
By Type:
Humira
Enbrel
Remicade
Others
By End-User:
Alzheimer's Diseases
Parkinson's Diseases
Ischemic Stroke
Multiple Sclerosis
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Tumor Necrosis Factor Inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Tumor Necrosis Factor Inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Tumor Necrosis Factor Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Tumor Necrosis Factor Inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Tumor Necrosis Factor Inhibitors Market Analysis and Outlook to 2022
-
7.1 Global Tumor Necrosis Factor Inhibitors Consumption (2017-2022)
-
7.2 United States Tumor Necrosis Factor Inhibitors Consumption (2017-2022)
-
7.3 Europe Tumor Necrosis Factor Inhibitors Consumption (2017-2022)
-
7.4 China Tumor Necrosis Factor Inhibitors Consumption (2017-2022)
-
7.5 Japan Tumor Necrosis Factor Inhibitors Consumption (2017-2022)
-
7.6 India Tumor Necrosis Factor Inhibitors Consumption (2017-2022)
-
7.7 South Korea Tumor Necrosis Factor Inhibitors Consumption (2017-2022)
8 Region and Country-wise Tumor Necrosis Factor Inhibitors Market Analysis and Outlook to 2028
-
8.1 Global Tumor Necrosis Factor Inhibitors Consumption Forecast (2022-2028)
-
8.2 United States Tumor Necrosis Factor Inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe Tumor Necrosis Factor Inhibitors Consumption Forecast (2022-2028)
-
8.4 China Tumor Necrosis Factor Inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan Tumor Necrosis Factor Inhibitors Consumption Forecast (2022-2028)
-
8.6 India Tumor Necrosis Factor Inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea Tumor Necrosis Factor Inhibitors Consumption Forecast (2022-2028)
9 Global Tumor Necrosis Factor Inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global Tumor Necrosis Factor Inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Humira Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Enbrel Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Remicade Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Tumor Necrosis Factor Inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Alzheimer's Diseases Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Parkinson's Diseases Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Ischemic Stroke Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Multiple Sclerosis Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Tumor Necrosis Factor Inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global Tumor Necrosis Factor Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Humira Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Enbrel Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Remicade Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Tumor Necrosis Factor Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Alzheimer's Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Parkinson's Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Ischemic Stroke Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Tumor Necrosis Factor Inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global Tumor Necrosis Factor Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Tumor Necrosis Factor Inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Tumor Necrosis Factor Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Tumor Necrosis Factor Inhibitors Market Competitive Analysis
-
14.1 Intas Pharmaceuticals
-
14.1.1 Intas Pharmaceuticals Company Details
-
14.1.2 Intas Pharmaceuticals Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Intas Pharmaceuticals Tumor Necrosis Factor Inhibitors Product and Service
-
14.2 Dexa Medica
-
14.2.1 Dexa Medica Company Details
-
14.2.2 Dexa Medica Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Dexa Medica Tumor Necrosis Factor Inhibitors Product and Service
-
14.3 GlaxoSmithKline
-
14.3.1 GlaxoSmithKline Company Details
-
14.3.2 GlaxoSmithKline Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GlaxoSmithKline Tumor Necrosis Factor Inhibitors Product and Service
-
14.4 LEO Pharma
-
14.4.1 LEO Pharma Company Details
-
14.4.2 LEO Pharma Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 LEO Pharma Tumor Necrosis Factor Inhibitors Product and Service
-
14.5 LG Life Sciences
-
14.5.1 LG Life Sciences Company Details
-
14.5.2 LG Life Sciences Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 LG Life Sciences Tumor Necrosis Factor Inhibitors Product and Service
-
14.6 MedImmune
-
14.6.1 MedImmune Company Details
-
14.6.2 MedImmune Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 MedImmune Tumor Necrosis Factor Inhibitors Product and Service
-
14.7 Momenta Pharmaceuticals
-
14.7.1 Momenta Pharmaceuticals Company Details
-
14.7.2 Momenta Pharmaceuticals Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Momenta Pharmaceuticals Tumor Necrosis Factor Inhibitors Product and Service
-
14.8 Janssen Biotech
-
14.8.1 Janssen Biotech Company Details
-
14.8.2 Janssen Biotech Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Janssen Biotech Tumor Necrosis Factor Inhibitors Product and Service
-
14.9 HanAll Biopharma
-
14.9.1 HanAll Biopharma Company Details
-
14.9.2 HanAll Biopharma Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 HanAll Biopharma Tumor Necrosis Factor Inhibitors Product and Service
-
14.10 Bionovis
-
14.10.1 Bionovis Company Details
-
14.10.2 Bionovis Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Bionovis Tumor Necrosis Factor Inhibitors Product and Service
-
14.11 EPIRUS Biopharmaceuticals
-
14.11.1 EPIRUS Biopharmaceuticals Company Details
-
14.11.2 EPIRUS Biopharmaceuticals Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 EPIRUS Biopharmaceuticals Tumor Necrosis Factor Inhibitors Product and Service
-
14.12 CASI Pharmaceuticals
-
14.12.1 CASI Pharmaceuticals Company Details
-
14.12.2 CASI Pharmaceuticals Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 CASI Pharmaceuticals Tumor Necrosis Factor Inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Tumor Necrosis Factor Inhibitors
-
Figure Tumor Necrosis Factor Inhibitors Picture
-
Table Global Tumor Necrosis Factor Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tumor Necrosis Factor Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tumor Necrosis Factor Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Tumor Necrosis Factor Inhibitors Consumption by Country (2017-2022)
-
Figure United States Tumor Necrosis Factor Inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe Tumor Necrosis Factor Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China Tumor Necrosis Factor Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan Tumor Necrosis Factor Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India Tumor Necrosis Factor Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea Tumor Necrosis Factor Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Tumor Necrosis Factor Inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States Tumor Necrosis Factor Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Tumor Necrosis Factor Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Tumor Necrosis Factor Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Tumor Necrosis Factor Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Tumor Necrosis Factor Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Tumor Necrosis Factor Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Humira Consumption and Growth Rate (2017-2022)
-
Figure Global Enbrel Consumption and Growth Rate (2017-2022)
-
Figure Global Remicade Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Alzheimer's Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Parkinson's Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Ischemic Stroke Consumption and Growth Rate (2017-2022)
-
Figure Global Multiple Sclerosis Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Humira Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Enbrel Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Remicade Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alzheimer's Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Parkinson's Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ischemic Stroke Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Tumor Necrosis Factor Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Tumor Necrosis Factor Inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table Intas Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Intas Pharmaceuticals Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Intas Pharmaceuticals Tumor Necrosis Factor Inhibitors Product and Service
-
Table Dexa Medica (Foundation Year, Company Profile and etc.)
-
Table Dexa Medica Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dexa Medica Tumor Necrosis Factor Inhibitors Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Tumor Necrosis Factor Inhibitors Product and Service
-
Table LEO Pharma (Foundation Year, Company Profile and etc.)
-
Table LEO Pharma Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table LEO Pharma Tumor Necrosis Factor Inhibitors Product and Service
-
Table LG Life Sciences (Foundation Year, Company Profile and etc.)
-
Table LG Life Sciences Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table LG Life Sciences Tumor Necrosis Factor Inhibitors Product and Service
-
Table MedImmune (Foundation Year, Company Profile and etc.)
-
Table MedImmune Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table MedImmune Tumor Necrosis Factor Inhibitors Product and Service
-
Table Momenta Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Momenta Pharmaceuticals Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Momenta Pharmaceuticals Tumor Necrosis Factor Inhibitors Product and Service
-
Table Janssen Biotech (Foundation Year, Company Profile and etc.)
-
Table Janssen Biotech Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Biotech Tumor Necrosis Factor Inhibitors Product and Service
-
Table HanAll Biopharma (Foundation Year, Company Profile and etc.)
-
Table HanAll Biopharma Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table HanAll Biopharma Tumor Necrosis Factor Inhibitors Product and Service
-
Table Bionovis (Foundation Year, Company Profile and etc.)
-
Table Bionovis Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bionovis Tumor Necrosis Factor Inhibitors Product and Service
-
Table EPIRUS Biopharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table EPIRUS Biopharmaceuticals Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table EPIRUS Biopharmaceuticals Tumor Necrosis Factor Inhibitors Product and Service
-
Table CASI Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table CASI Pharmaceuticals Tumor Necrosis Factor Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table CASI Pharmaceuticals Tumor Necrosis Factor Inhibitors Product and Service
-
